Salvus Wealth Management, LLC Pfizer Inc Transaction History

Salvus Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$36.12 - $41.79 $17,626 - $20,393	488 Added 2.72%	18,429 $675,000
Q1 2023 Apr 11, 2023	BUY	$39.39 - $51.28 $19,419 - $25,281	493 Added 2.83%	17,941 $731,000
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $44,004 - $57,443	-1,054 Reduced 5.7%	17,448 $0
Q3 2022 Oct 12, 2022	BUY	$43.76 - $53.42 $30,456 - $37,180	696 Added 3.91%	18,502 $810,000
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $3,675 - $4,358	-79 Reduced 0.44%	17,806 $934,000
Q1 2022 Apr 11, 2022	SELL	$45.75 - $56.69 $424,285 - $525,743	-9,274 Reduced 34.15%	17,885 $926,000
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $4,462 - $6,615	-108 Reduced 0.4%	27,159 $1.6 Million
Q3 2021 Oct 05, 2021	BUY	$39.25 - $50.42 $34,186 - $43,915	871 Added 3.3%	27,267 $1.17 Million
Q2 2021 Jul 09, 2021	BUY	$35.91 - $40.68 $13,466 - $15,255	375 Added 1.44%	26,396 $1.04 Million
Q1 2021 Apr 09, 2021	BUY	$33.49 - $37.77 $31,982 - $36,070	955 Added 3.81%	26,021 $936,000
Q4 2020 Jan 15, 2021	BUY	$33.47 - $42.56 $838,959 - $1.07 Million	25,066 New	25,066 $931,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Salvus Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Salvus Wealth Management, LLC with notifications on news.